Beckton Dickenson is doing the LP002 "bridge test"
Post# of 30028
Posted On: 10/08/2014 3:24:30 PM
Beckton Dickenson is doing the LP002 "bridge test" in their San Diego lab, I believe. That is the univariant data Gerald will be releasing this week.
The 12 week validation test is being done by ICON in their New York lab, I believe. Gerald said the data from the "bridge" will help them. Their test will be completed around December 1st. They will be releasing multivariant data. What is important about this validation test is that it is proving ICON can duplicate what BecKton Dickenson has done in their labs.This is the last step before commercializing Lympro. Because it will be happening in December during the holidays, January will be the true public launch.
I believe Gerald said they would begin doing some "soft selling" to pharmas doing AD clinical trials in November.
The 12 week validation test is being done by ICON in their New York lab, I believe. Gerald said the data from the "bridge" will help them. Their test will be completed around December 1st. They will be releasing multivariant data. What is important about this validation test is that it is proving ICON can duplicate what BecKton Dickenson has done in their labs.This is the last step before commercializing Lympro. Because it will be happening in December during the holidays, January will be the true public launch.
I believe Gerald said they would begin doing some "soft selling" to pharmas doing AD clinical trials in November.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼